Crohn's Disease Registries


Cimzia® Registry

Principal Investigator: Ellen Zimmermann, MD

This is a registry study to collect information on the long-term use and safety of Cimzia® as compared to other Crohn's disease medications prescribed by your doctor in routine clinical practice. Patients enrolled in this study will complete surveys about their social and medical history. Additionally, at your regularly scheduled office visits, you will be asked to provide information regarding your CD symptoms and other relevant information about your health and medications. UCB Inc. is the sponsor for this study. Patients who have been prescribed Cimzia® by their physician to treat CD are able to participate in this study.


Tysabri® Registry

Principal Investigator: Ellen Zimmermann, MD

This is a registry study to collect information on the long-term use and safety of Tysabri® as compared to other Crohn's disease medications prescribed by your doctor in routine clinical practice. Elan Pharmaceuticals is the sponsor of this study. Eligible patients are those who have been prescribed Tysabri® by their physician for the treatment of Crohn's disease.


Contact person: